Nexus Pharmaceuticals
US-based, family-owned, minority-led pharmaceutical manufacturer focused on development, sterile manufacturing, regulatory approval, and commercial launch of specialty injectable medicines, including first-to-market and generic vial products for hospital and institutional use.
Industries
Nr. of Employees
medium (51-250)
Products
Cyclophosphamide Injection (multiple-dose vials, 2.5 mL and 5 mL fills)
Ready-to-dilute vial presentations of an oncology injectable provided in multiple-dose vial formats with refrigerated storage instructions.
Tacrolimus Injection (5 mg/mL, vial)
Single-dose vial formulation of an immunosuppressant drug for prevention of organ rejection.
Methylene Blue Injection, USP (vial)
Injectable diagnostic/therapeutic agent produced and approved for treatment of acquired methemoglobinemia.
Fluorescein Injection (10% and 25% vial presentations)
Ophthalmic diagnostic injectable presentations provided in multiple vial sizes and concentrations.
Phenobarbital Sodium Injection, USP (65 mg/mL and 130 mg/mL)
Vial formulations of a barbiturate injectable product with package insert and safety data sheet available; provided with NDC and ordering codes.
Baclofen Injection Refill Kit (vial-based)
Vial-based refill kit presentation intended for management of long-term severe spasticity.
Cyclophosphamide Injection (multiple-dose vials, 2.5 mL and 5 mL fills)
Ready-to-dilute vial presentations of an oncology injectable provided in multiple-dose vial formats with refrigerated storage instructions.
Tacrolimus Injection (5 mg/mL, vial)
Single-dose vial formulation of an immunosuppressant drug for prevention of organ rejection.
Methylene Blue Injection, USP (vial)
Injectable diagnostic/therapeutic agent produced and approved for treatment of acquired methemoglobinemia.
Fluorescein Injection (10% and 25% vial presentations)
Ophthalmic diagnostic injectable presentations provided in multiple vial sizes and concentrations.
Phenobarbital Sodium Injection, USP (65 mg/mL and 130 mg/mL)
Vial formulations of a barbiturate injectable product with package insert and safety data sheet available; provided with NDC and ordering codes.
Baclofen Injection Refill Kit (vial-based)
Vial-based refill kit presentation intended for management of long-term severe spasticity.
Expertise Areas
- Specialty sterile injectable manufacturing
- Formulation development and lyophilization
- Regulatory submissions and FDA approvals for injectables
- Generic injectable product development and abbreviated pathways
Key Technologies
- Sterile injectable formulation
- Lyophilization (freeze-drying)
- Aseptic vial filling
- Cold chain storage and distribution
News & Updates
Announcement of FDA approval for a vial formulation of tacrolimus intended to expand immunosuppressive therapy options.
Announcement of FDA approval of methylene blue injection for treatment of acquired methemoglobinemia.
Commercial launch of ready-to-dilute cyclophosphamide injection in multiple-dose vials.
Announcement of the commercial launch of tacrolimus injection in single-dose vial format.
Multiple product approvals announced for injectable medicines, including immunosuppressive and diagnostic agents.
Announcement of FDA approval for a vial formulation of tacrolimus intended to expand immunosuppressive therapy options.
Announcement of FDA approval of methylene blue injection for treatment of acquired methemoglobinemia.
Commercial launch of ready-to-dilute cyclophosphamide injection in multiple-dose vials.
Announcement of the commercial launch of tacrolimus injection in single-dose vial format.
Multiple product approvals announced for injectable medicines, including immunosuppressive and diagnostic agents.